| 1635 |
Supervision by DTO at TU level |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1641 |
Program Monitoring Indicators |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1642 |
NTEP TB Index - Indicators |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1643 |
NTEP Performance Indicator - Percentage of Target TB Notification Achieved |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1644 |
RCA for Low Performance in Percentage of Target TB Notification Achieved |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1645 |
NTEP Performance Indicator - Percentage of TB Notified Patients with Known HIV Status |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1646 |
RCA for low performance of Percentage of TB Notified Patients with known HIV Status |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1647 |
NTEP Performance Indicator - Percentage of TB Notified Patients with Universal Drug Susceptibility Testing (UDST) Done |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1648 |
Root cause analysis for low performance of Percentage of TB Notified Cases with Universal Drug Susceptibility Testing Done |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1649 |
NTEP Performance Indicator - Treatment Success Rate |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1650 |
Root Cause Analysis for Low Performance - Suggested Solutions - Case Studies along 4 |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1651 |
NTEP Performance Indicator - Percentage of Eligible Beneficiaries Paid Under Ni-kshay Poshan Yojana |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1652 |
Root cause analysis for low performance of Percentage of Eligible Beneficiaries Paid under Ni-kshay Poshan Yojana |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1653 |
NTEP Performance Indicator – Percentage Of Multidrug-resistant (MDR)/ Rifampicin-resistant (RR) Patients Initiated on Treatment Out of Totally Diagnosed |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1654 |
RCA for low performance in in Percentage Treatment initiation of RR/MDR-TB Cases |
05/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1655 |
NTEP Performance Indicator - Percentage Expenditure Against Approved Record of Proceedings (ROP) |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1656 |
Root cause analysis for low performance of Percentage Expenditure Against Approved Record of Proceedings [ROP] |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1657 |
NTEP Performance Indicator - Percentage of Children given Chemoprophylaxis from the Total Eligible Children Identified |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1658 |
RCA for low performance in Percentage of Children given TPT from the Total Eligible Children Identified |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1659 |
NTEP Performance Indicator - Percentage of People Living with HIV (PLHIV) given INH Preventive Treatment (IPT) Against Total Eligible PLHIV |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1660 |
RCA for low performance in in percentage of PLHIV given IPT against Total Eligible |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1683 |
Meetings at TU level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1684 |
Conducting review meetings at TU/Block level |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1795 |
Factors Affecting the Severity of TB Disease |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 1982 |
TB deaths |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2042 |
Random Blinded ReChecking [RBRC] Interpreting Feedback |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2089 |
Zoonotic TB |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2090 |
Zoonotic TB: Mode of transmission |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2091 |
Zoonotic TB: Signs and symptoms |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
| 2092 |
Zoonotic TB: Testing and diagnosis |
06/06/2024 |
Surveillance, SM&E and Epidemiology |
